The National Research Nuclear University MEPhI in Russia has inaugurated a new Laboratory for Regenerative Technologies and Tissue Engineering, backed by the State Atomic Energy Corporation Rosatom.

The laboratory aims to serve as a hub for biomedical innovation and the training of future professionals in the field.

It will focus on growing biocompatible blood vessel equivalents using patients' cells, with a biofabricator developed by Rosatom scientists designed to simulate tissue growth on a micro level.

The official opening of the laboratory took place on March 5, 2025. The ceremony featured speeches from Vladimir Shevchenko, Rector of MEPhI; Dmitry Baidarov, Director of the New Businesses Support Department at Rosatom; Igor Reshetov, cancer surgeon at I.M. Sechenov First Moscow State Medical University; Vladislav Parfenov, Head of the 3D Bioprinting Center at MEPhI; and Alexander Garmash, Director of the Institute for Physics and Engineering in Biomedicine at MEPhI.

The speakers highlighted the importance of an interdisciplinary approach to the development of cutting-edge medical technologies and the training of future professionals.

Vladimir Shevchenko emphasized the crucial role of integrating physical research techniques, diagnostic tools, and analytical methods in advancing biomedicine, stating, "The tremendous advances in biomedicine and life sciences over the past few decades have been made possible through the integration of high-precision devices like magnetic resonance imaging systems and lasers.”

“I hope this laboratory will lead to new approaches and ideas to combat diseases that are currently considered incurable," he added.

Dmitry Baidarov also underlined the importance of equipping students with the necessary skills to navigate emerging technologies, noting, “It is imperative for universities to update their educational programs so that laboratories like this can start yielding results as soon as possible."

Following the opening ceremony, a seminar was held to discuss the future of nuclear medicine and biotechnology.

—